The Unlikely Alliance: Asthma and Weight Loss Drugs A recent study presented at the European Respiratory Society Congress in Barcelona, Spain, has shed new light on the relationship between respiratory health and metabolic management.
Researchers found that patients with asthma using semaglutide, a weight loss drug, may experience fewer attacks.
The connection between semaglutide and reduced asthma or chronic obstructive pulmonary disease (COPD) flare ups is significant.